Human innate lymphoid cells

Journal of Allergy and Clinical Immunology

Volumn 138, Issue 5, 2016, Pages 1265-1276

  Mjösberg, Jenny ^a   Spits, Hergen ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

allergy; asthma; graft versus host disease; inflammatory bowel disease; Innate lymphoid cells; mucosal immunity; psoriasis; tumor immunity

Indexed keywords

ARTICLE; CELL FUNCTION; CELL HETEROGENEITY; CELL MATURATION; CELL PLASTICITY; CLASSIFICATION; DERMATITIS; ENTERITIS; FILARIASIS; GASTROINTESTINAL INFECTION; GRAFT VERSUS HOST REACTION; HOMEOSTASIS; HUMAN; LYMPHOID CELL; LYMPHOID ORGAN; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYSTEM; TISSUE REPAIR; ANIMAL; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE;

ANIMALS; HUMANS; IMMUNITY, INNATE; LYMPHOCYTES;

EID: 84994876918     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.09.009     Document Type: Article

References (115)

1. 1 Spits, H., Bernink, J.H., Lanier, L., NK cells and type 1 innate lymphoid cells: partners in host defense. Nat Immunol 17 (2016), 758–764.
2. 2 Fuchs, A., Vermi, W., Lee, J.S., Lonardi, S., Gilfillan, S., Newberry, R.D., et al. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 38 (2013), 769–781.
3. 3 Klose, C.S., Flach, M., Mohle, L., Rogell, L., Hoyler, T., Ebert, K., et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157 (2014), 340–356.
4. 4 Klose, C.S., Kiss, E.A., Schwierzeck, V., Ebert, K., Hoyler, T., d'Hargues, Y., et al. A T-bet gradient controls the fate and function of CCR6(−)RORgammat(+) innate lymphoid cells. Nature 494 (2013), 261–265.
5. 5 Bernink, J.H., Mjösberg, J.M., Peters, C.P., Munneke, M., Te Velde, A.A., Meijer, S.L., et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 14 (2013), 221–229.
6. 6 Bal, S.M., Bernink, J.H., Nagasawa, M., Groot, J., Shikhagaie, M.M., Golebski, K., et al. IL-1beta, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol 17 (2016), 636–645.
7. 7 Hoyler, T., Klose, C.S., Souabni, A., Turqueti-Neves, A., Pfeifer, D., Rawlins, E.L., et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37 (2012), 634–648.
8. 8 Mjösberg, J., Bernink, J., Golebski, K., Karrich, J.J., Peters, C.P., Blom, B., et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37 (2012), 649–659.
9. 9 Halim, T.Y., MacLaren, A., Romanish, M.T., Gold, M.J., McNagny, K.M., Takei, F., Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity 37 (2012), 463–474.
10. 10 Cella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J.K., et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457 (2009), 722–725.
11. 11 Cupedo, T., Crellin, N.K., Papazian, N., Rombouts, E.J., Weijer, K., Grogan, J.L., et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 10 (2009), 66–74.
12. 12 Ohne, Y., Silver, J.S., Thompson-Snipes, L., Collet, M.A., Blanck, J.P., Cantarel, B.L., et al. IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. Nat Immunol 17 (2016), 646–655.
13. 13 Lim, A.I., Menegatti, S., Bustamante, J., Le Bourhis, L., Allez, M., Rogge, L., et al. IL-12 drives functional plasticity of human group 2 innate lymphoid cells. J Exp Med 213 (2016), 569–583.
14. 14 Bernink, J.H., Krabbendam, L., Germar, K., de Jong, E., Gronke, K., Kofoed-Nielsen, M., et al. Interleukin-12 and -23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43 (2015), 146–160.
15. 15 Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463 (2010), 540–544.
16. 16 Neill, D.R., Wong, S.H., Bellosi, A., Flynn, R.J., Daly, M., Langford, T.K., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464 (2010), 1367–1370.
17. 17 Price, A.E., Liang, H.E., Sullivan, B.M., Reinhardt, R.L., Eisley, C.J., Erle, D.J., et al. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A 107 (2010), 11489–11494.
18. 18 Mjösberg, J.M., Trifari, S., Crellin, N.K., Peters, C.P., van Drunen, C.M., Piet, B., et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12 (2011), 1055–1062.
19. 19 Monticelli, L.A., Sonnenberg, G.F., Abt, M.C., Alenghat, T., Ziegler, C.G., Doering, T.A., et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12 (2011), 1045–1054.
20. 20 Kim, B.S., Siracusa, M.C., Saenz, S.A., Noti, M., Monticelli, L.A., Sonnenberg, G.F., et al. TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med, 5, 2013, 170ra16.
21. 21 Salimi, M., Barlow, J.L., Saunders, S.P., Xue, L., Gutowska-Owsiak, D., Wang, X., et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 210 (2013), 2939–2950.
22. 22 Hoorweg, K., Peters, C.P., Cornelissen, F., Aparicio-Domingo, P., Papazian, N., Kazemier, G., et al. Functional differences between human NKp44(-) and NKp44(+) RORC(+) innate lymphoid cells. Front Immunol, 3, 2012, 72.
23. 23 Bjorklund, A.K., Forkel, M., Picelli, S., Konya, V., Theorell, J., Friberg, D., et al. The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing. Nat Immunol 17 (2016), 451–460.
24. 24 Satoh-Takayama, N., Vosshenrich, C.A., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29 (2008), 958–970.
25. 25 Crellin, N.K., Trifari, S., Kaplan, C.D., Cupedo, T., Spits, H., Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J Exp Med 207 (2010), 281–290.
26. 26 Buonocore, S., Ahern, P.P., Uhlig, H.H., Ivanov II, Littman, D.R., Maloy, K.J., et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464 (2010), 1371–1375.
27. 27 Geremia, A., Arancibia-Carcamo, C.V., Fleming, M.P., Rust, N., Singh, B., Mortensen, N.J., et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 208 (2011), 1127–1133.
28. 28 Eberl, G., Marmon, S., Sunshine, M.J., Rennert, P.D., Choi, Y., Littman, D.R., An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 5 (2004), 64–73.
29. 29 Yang, Q., Bhandoola, A., The development of adult innate lymphoid cells. Curr Opin Immunol 39 (2016), 114–120.
30. 30 Zook, E.C., Kee, B.L., Development of innate lymphoid cells. Nat Immunol 17 (2016), 775–782.
31. 31 Constantinides, M.G., McDonald, B.D., Verhoef, P.A., Bendelac, A., A committed precursor to innate lymphoid cells. Nature 508 (2014), 397–401.
32. 32 Yang, Q., Li, F., Harly, C., Xing, S., Ye, L., Xia, X., et al. TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow. Nat Immunol 16 (2015), 1044–1050.
33. 33 Male, V., Nisoli, I., Kostrzewski, T., Allan, D.S., Carlyle, J.R., Lord, G.M., et al. The transcription factor E4bp4/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression. J Exp Med 211 (2014), 635–642.
34. 34 Constantinides, M.G., Gudjonson, H., McDonald, B.D., Ishizuka, I.E., Verhoef, P.A., Dinner, A.R., et al. PLZF expression maps the early stages of ILC1 lineage development. Proc Natl Acad Sci U S A 112 (2015), 5123–5128.
35. 35 Montaldo, E., Teixeira-Alves, L.G., Glatzer, T., Durek, P., Stervbo, U., Hamann, W., et al. Human RORgammat(+)CD34(+) cells are lineage-specified progenitors of group 3 RORgammat(+) innate lymphoid cells. Immunity 41 (2014), 988–1000.
36. 36 Scoville, S.D., Mundy-Bosse, B.L., Zhang, M.H., Chen, L., Zhang, X., Keller, K.A., et al. A progenitor cell expressing transcription factor RORgammat generates all human innate lymphoid cell subsets. Immunity 44 (2016), 1140–1150.
37. 37 Renoux, V.M., Zriwil, A., Peitzsch, C., Michaelsson, J., Friberg, D., Soneji, S., et al. Identification of a human natural killer cell lineage-restricted progenitor in fetal and adult tissues. Immunity 43 (2015), 394–407.
38. 38 Moretta, F., Petronelli, F., Lucarelli, B., Pitisci, A., Bertaina, A., Locatelli, F., et al. The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF. Eur J Immunol 46 (2016), 1271–1278.
39. 39 Seehus, C.R., Aliahmad, P., de la Torre, B., Iliev, I.D., Spurka, L., Funari, V.A., et al. The development of innate lymphoid cells requires TOX-dependent generation of a common innate lymphoid cell progenitor. Nat Immunol 16 (2015), 599–608.
40. 40 Yu, X., Wang, Y., Deng, M., Li, Y., Ruhn, K.A., Zhang, C.C., et al. The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor. Elife, 3, 2014, 10.7554/eLife.04406.
41. 41 Yokota, Y., Mansouri, A., Mori, S., Sugawara, S., Adachi, S., Nishikawa, S., et al. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397 (1999), 702–706.
42. 42 Yagi, R., Zhong, C., Northrup, D.L., Yu, F., Bouladoux, N., Spencer, S., et al. The transcription factor GATA3 is critical for the development of all IL-7Ralpha-expressing innate lymphoid cells. Immunity 40 (2014), 378–388.
43. 43 Yu, Y., Wang, C., Clare, S., Wang, J., Lee, S.C., Brandt, C., et al. The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development. J Exp Med 212 (2015), 865–874.
44. 44 Ghaedi, M., Steer, C.A., Martinez-Gonzalez, I., Halim, T.Y., Abraham, N., Takei, F., Common-lymphoid-progenitor-independent pathways of innate and T lymphocyte development. Cell Rep 15 (2016), 471–480.
45. 45 Gentek, R., Munneke, J.M., Helbig, C., Blom, B., Hazenberg, M.D., Spits, H., et al. Modulation of signal strength switches notch from an inducer of T cells to an inducer of ILC2. Front Immunol, 4, 2013, 334.
46. 46 Gasteiger, G., Fan, X., Dikiy, S., Lee, S.Y., Rudensky, A.Y., Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350 (2015), 981–985.
47. 47 Narni-Mancinelli, E., Chaix, J., Fenis, A., Kerdiles, Y.M., Yessaad, N., Reynders, A., et al. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc Natl Acad Sci U S A 108 (2011), 18324–18329.
48. 48 Rankin, L.C., Girard-Madoux, M.J., Seillet, C., Mielke, L.A., Kerdiles, Y., Fenis, A., et al. Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nat Immunol 17 (2016), 179–186.
49. 49 Song, C., Lee, J.S., Gilfillan, S., Robinette, M.L., Newberry, R.D., Stappenbeck, T.S., et al. Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation. J Exp Med 212 (2015), 1869–1882.
50. 50 Vely, F., Barlogis, V., Vallentin, B., Neven, B., Piperoglou, C., Perchet, T., et al. Evidence of innate lymphoid cell redundancy in humans. Nat Immunol, 2016 [Epub ahead of print] http://dx.doi.org/10.1038/ni.3553.
51. 51 Bar-Ephraim, Y.E., Mebius, R.E., Innate lymphoid cells in secondary lymphoid organs. Immunol Rev 271 (2016), 185–199.
52. 52 van de Pavert, S.A., Mebius, R.E., New insights into the development of lymphoid tissues. Nat Rev Immunol 10 (2010), 664–674.
53. 53 Mebius, R.E., Rennert, P., Weissman, I.L., Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7 (1997), 493–504.
54. 54 Sawa, S., Cherrier, M., Lochner, M., Satoh-Takayama, N., Fehling, H.J., Langa, F., et al. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 330 (2010), 665–669.
55. 55 van de Pavert, S.A., Ferreira, M., Domingues, R.G., Ribeiro, H., Molenaar, R., Moreira-Santos, L., et al. Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature 508 (2014), 123–127.
56. 56 Facchetti, F., Blanzuoli, L., Ungari, M., Alebardi, O., Vermi, W., Lymph node pathology in primary combined immunodeficiency diseases. Springer Semin Immunopathol 19 (1998), 459–478.
57. 57 Okada, S., Markle, J.G., Deenick, E.K., Mele, F., Averbuch, D., Lagos, M., et al. Immunodeficiencies. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science 349 (2015), 606–613.
58. 58 Robinette, M.L., Fuchs, A., Cortez, V.S., Lee, J.S., Wang, Y., Durum, S.K., et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat Immunol 16 (2015), 306–317.
59. 59 Sonnenberg, G.F., Artis, D., Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat Med 21 (2015), 698–708.
60. 60 Hanash, A.M., Dudakov, J.A., Hua, G., O'Connor, M.H., Young, L.F., Singer, N.V., et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 37 (2012), 339–350.
61. 61 Sonnenberg, G.F., Monticelli, L.A., Alenghat, T., Fung, T.C., Hutnick, N.A., Kunisawa, J., et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336 (2012), 1321–1325.
62. 62 Hazenberg, M.D., Spits, H., Human innate lymphoid cells. Blood 124 (2014), 700–709.
63. 63 Trifari, S., Kaplan, C.D., Tran, E.H., Crellin, N.K., Spits, H., Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10 (2009), 864–871.
64. 64 Basu, R., O'Quinn, D.B., Silberger, D.J., Schoeb, T.R., Fouser, L., Ouyang, W., et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 37 (2012), 1061–1075.
65. 65 Hepworth, M.R., Monticelli, L.A., Fung, T.C., Ziegler, C.G., Grunberg, S., Sinha, R., et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498 (2013), 113–117.
66. 66 Hepworth, M.R., Fung, T.C., Masur, S.H., Kelsen, J.R., McConnell, F.M., Dubrot, J., et al. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells. Science 348 (2015), 1031–1035.
67. 67 Hueber, W., Sands, B.E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P.D., et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61 (2012), 1693–1700.
68. 68 Lee, J.S., Tato, C.M., Joyce-Shaikh, B., Gulen, M.F., Cayatte, C., Chen, Y., et al. Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity 43 (2015), 727–738.
69. 69 Li, J., Doty, A.L., Iqbal, A., Glover, S.C., The differential frequency of Lineage(−)CRTH2(−)CD45(+)NKp44(−)CD117(−)CD127(+)ILC subset in the inflamed terminal ileum of patients with Crohn's disease. Cell Immunol 304-305 (2016), 63–68.
70. 70 Takayama, T., Kamada, N., Chinen, H., Okamoto, S., Kitazume, M.T., Chang, J., et al. Imbalance of NKp44(+)NKp46(−) and NKp44(−)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease. Gastroenterology 139 (2010), 882–892 e1-3.
71. 71 Mannon, P.J., Fuss, I.J., Mayer, L., Elson, C.O., Sandborn, W.J., Present, D., et al. Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med 351 (2004), 2069–2079.
72. 72 Klose, C.S., Artis, D., Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat Immunol 17 (2016), 765–774.
73. 73 Oliphant, C.J., Hwang, Y.Y., Walker, J.A., Salimi, M., Wong, S.H., Brewer, J.M., et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 41 (2014), 283–295.
74. 74 Halim, T.Y., Steer, C.A., Matha, L., Gold, M.J., Martinez-Gonzalez, I., McNagny, K.M., et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40 (2014), 425–435.
75. 75 Walker, J.A., Barlow, J.L., McKenzie, A.N., Innate lymphoid cells—how did we miss them?. Nat Rev Immunol 13 (2013), 75–87.
76. 76 Kim, H.Y., Umetsu, D.T., Dekruyff, R.H., Innate lymphoid cells in asthma: will they take your breath away?. Eur J Immunol 46 (2016), 795–806.
77. 77 Shaw, J.L., Fakhri, S., Citardi, M.J., Porter, P.C., Corry, D.B., Kheradmand, F., et al. IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med 188 (2013), 432–439.
78. 78 Gevaert, P., Van Bruaene, N., Cattaert, T., Van Steen, K., Van Zele, T., Acke, F., et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 128 (2011), 989–995 e1-8.
79. 79 Gevaert, P., Lang-Loidolt, D., Lackner, A., Stammberger, H., Staudinger, H., Van Zele, T., et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 118 (2006), 1133–1141.
80. 80 Wenzel, S., Ford, L., Pearlman, D., Spector, S., Sher, L., Skobieranda, F., et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 368 (2013), 2455–2466.
81. 81 Smith, S.G., Chen, R., Kjarsgaard, M., Huang, C., Oliveria, J.P., O'Byrne, P.M., et al. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol 137 (2016), 75–86.e8.
82. 82 Nagakumar, P., Denney, L., Fleming, L., Bush, A., Lloyd, C.M., Saglani, S., Type 2 innate lymphoid cells in induced sputum from children with severe asthma. J Allergy Clin Immunol 137 (2016), 624–626.e6.
83. 83 Christianson, C.A., Goplen, N.P., Zafar, I., Irvin, C., Good, J.T. Jr., Rollins, D.R., et al. Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol 136 (2015), 59–68.e14.
84. 84 Bartemes, K.R., Kephart, G.M., Fox, S.J., Kita, H., Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol 134 (2014), 671–678.e4.
85. 85 Duerr, C.U., McCarthy, C.D., Mindt, B.C., Rubio, M., Meli, A.P., Pothlichet, J., et al. Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells. Nat Immunol 17 (2016), 65–75.
86. 86 Moro, K., Kabata, H., Tanabe, M., Koga, S., Takeno, N., Mochizuki, M., et al. Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses. Nat Immunol 17 (2016), 76–86.
87. 87 Konya, V., Mjosberg, J., Lipid mediators as regulators of human ILC2 function in allergic diseases. Immunol Lett, 2016 [Epub ahead of print] http://dx.doi.org/10.1016/j.imlet.2016.07.006.
88. 88 Xue, L., Salimi, M., Panse, I., Mjosberg, J.M., McKenzie, A.N., Spits, H., et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol 133 (2014), 1184–1194.
89. 89 Barnig, C., Cernadas, M., Dutile, S., Liu, X., Perrella, M.A., Kazani, S., et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med, 5, 2013, 174ra26.
90. 90 Silver, J.S., Kearley, J., Copenhaver, A.M., Sanden, C., Mori, M., Yu, L., et al. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat Immunol 17 (2016), 626–635.
91. 91 Roos, A.B., Sethi, S., Nikota, J., Wrona, C.T., Dorrington, M.G., Sanden, C., et al. IL-17A and the promotion of neutrophilia in acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 192 (2015), 428–437.
92. 92 Richmond, J.M., Harris, J.E., Immunology and skin in health and disease. Cold Spring Harb Perspect Med, 4, 2014, a015339.
93. 93 Villanova, F., Flutter, B., Tosi, I., Grys, K., Sreeneebus, H., Perera, G.K., et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol 134 (2014), 984–991.
94. 94 Dyring-Andersen, B., Geisler, C., Aggerbeck, C., Lauritsen, J.P., Gudjonsdottir, S.D., Skov, L., et al. Increased number and frequency of group 3 innate lymphoid cells in non-lesional psoriatic skin. Br J Dermatol 170 (2014), 609–616.
95. 95 Teunissen, M.B., Munneke, J.M., Bernink, J.H., Spuls, P.I., Res, P.C., Te Velde, A., et al. Composition of innate lymphoid cell (ILC) subsets in the human skin: enrichment of NCR ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol 134 (2014), 2351–2360.
96. 96 Munneke, J.M., Bjorklund, A.T., Mjosberg, J.M., Garming-Legert, K., Bernink, J.H., Blom, B., et al. Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease. Blood 124 (2014), 812–821.
97. 97 Roediger, B., Kyle, R., Yip, K.H., Sumaria, N., Guy, T.V., Kim, B.S., et al. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat Immunol 14 (2013), 564–573.
98. 98 Rak, G.D., Osborne, L.C., Siracusa, M.C., Kim, B.S., Wang, K., Bayat, A., et al. IL-33-dependent group 2 innate lymphoid cells promote cutaneous wound healing. J Invest Dermatol 136 (2016), 487–496.
99. 99 Saunders, S.P., Moran, T., Floudas, A., Wurlod, F., Kaszlikowska, A., Salimi, M., et al. Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity. J Allergy Clin Immunol 137 (2016), 482–491.
100. 100 Wojno, E.D., Monticelli, L.A., Tran, S.V., Alenghat, T., Osborne, L.C., Thome, J.J., et al. The prostaglandin D(2) receptor CRTH2 regulates accumulation of group 2 innate lymphoid cells in the inflamed lung. Mucosal Immunol 8 (2015), 1313–1323.
101. 101 Salimi, M., Xue, L., Jolin, H., Hardman, C., Cousins, D.J., McKenzie, A.N., et al. Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production. J Immunol 196 (2016), 45–54.
102. 102 Leijten, E.F., van Kempen, T.S., Boes, M., Michels-van Amelsfort, J.M., Hijnen, D., Hartgring, S.A., et al. Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid. Arthritis Rheumatol 67 (2015), 2673–2678.
103. 103 Pantelyushin, S., Haak, S., Ingold, B., Kulig, P., Heppner, F.L., Navarini, A.A., et al. Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J Clin Invest 122 (2012), 2252–2256.
104. 104 Crellin, N.K., Trifari, S., Kaplan, C.D., Satoh-Takayama, N., Di Santo, J.P., Spits, H., Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 33 (2010), 752–764.
105. 105 Kloverpris, H.N., Kazer, S.W., Mjosberg, J., Mabuka, J.M., Wellmann, A., Ndhlovu, Z., et al. Innate lymphoid cells are depleted irreversibly during acute HIV-1 infection in the absence of viral suppression. Immunity 44 (2016), 391–405.
106. 106 Xu, H., Wang, X., Lackner, A.A., Veazey, R.S., Type 3 innate lymphoid cell depletion is mediated by TLRs in lymphoid tissues of simian immunodeficiency virus-infected macaques. FASEB J 29 (2015), 5072–5080.
107. 107 Boyd, A., Ribeiro, J.M., Nutman, T.B., Human CD117 (cKit)+ innate lymphoid cells have a discrete transcriptional profile at homeostasis and are expanded during filarial infection. PLoS One, 9, 2014, e108649.
108. 108 Knorr, D.A., Bachanova, V., Verneris, M.R., Miller, J.S., Clinical utility of natural killer cells in cancer therapy and transplantation. Semin Immunol 26 (2014), 161–172.
109. 109 Carrega, P., Loiacono, F., Di Carlo, E., Scaramuccia, A., Mora, M., Conte, R., et al. NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. Nat Commun, 6, 2015, 8280.
110. 110 Glatzer, T., Killig, M., Meisig, J., Ommert, I., Luetke-Eversloh, M., Babic, M., et al. RORgammat(+) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 38 (2013), 1223–1235.
111. 111 Eisenring, M., vom Berg, J., Kristiansen, G., Saller, E., Becher, B., IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46. Nat Immunol 11 (2010), 1030–1038.
112. 112 Dadi, S., Chhangawala, S., Whitlock, B.M., Franklin, R.A., Luo, C.T., Oh, S.A., et al. Cancer immunosurveillance by tissue-resident innate lymphoid cells and innate-like T cells. Cell 164 (2016), 365–377.
113. 113 Kirchberger, S., Royston, D.J., Boulard, O., Thornton, E., Franchini, F., Szabady, R.L., et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 210 (2013), 917–931.
114. 114 Li, J., Razumilava, N., Gores, G.J., Walters, S., Mizuochi, T., Mourya, R., et al. Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation. J Clin Invest 124 (2014), 3241–3251.
115. 115 Vivier, E., van de Pavert, S.A., Cooper, M.D., Belz, G.T., The evolution of innate lymphoid cells. Nat Immunol 17 (2016), 790–794.